Association for Cancer Immunotherapy CIMT
@cimt.bsky.social
The Association for Cancer Immunotherapy CIMT is a not-for-profit information and education platform that fosters the development and translation of cancer immunotherapies .
“Scientific progress happens when scientists come together.” - Özlem Türeci/ At #CICON25 in Utrecht, we bring together the global cancer immunotherapy community . Register at www.cancerimmunotherapyconference.org
July 23, 2025 at 9:02 AM
“Scientific progress happens when scientists come together.” - Özlem Türeci/ At #CICON25 in Utrecht, we bring together the global cancer immunotherapy community . Register at www.cancerimmunotherapyconference.org
June 12 (midnight CET) is the abstract submission deadline for #CICON25. www.cancerimmunotherapyconference.org
June 11, 2025 at 11:46 AM
June 12 (midnight CET) is the abstract submission deadline for #CICON25. www.cancerimmunotherapyconference.org
Submit your abstract to #CICON25 in #Utrecht and present your research as poster or short talk: cancerimmunotherapyconference.org
May 22, 2025 at 11:46 AM
Submit your abstract to #CICON25 in #Utrecht and present your research as poster or short talk: cancerimmunotherapyconference.org
Can metastatic cancer be outsmarted by using the body’s innate immune system? At #CIMT2025, @maria-sibilia.bsky.social will present translational insights from mechanisms to therapeutics—exploring how the innate immune system can be harnessed to fight metastatic disease. www.meeting.cimt.eu
April 23, 2025 at 1:24 PM
Can metastatic cancer be outsmarted by using the body’s innate immune system? At #CIMT2025, @maria-sibilia.bsky.social will present translational insights from mechanisms to therapeutics—exploring how the innate immune system can be harnessed to fight metastatic disease. www.meeting.cimt.eu
Your front-row seat to the latest in cancer immunotherapy: www.cancerimmunotherapyconference.org Sept 10-12 in Utrecht @cancerresearchinst.bsky.social @enci-network.bsky.social
April 16, 2025 at 11:42 AM
Your front-row seat to the latest in cancer immunotherapy: www.cancerimmunotherapyconference.org Sept 10-12 in Utrecht @cancerresearchinst.bsky.social @enci-network.bsky.social
The Swedish cancer immunologist and researcher Rolf Kiessling @ki.se is the recipient of the 2025 CIMT Lifetime Achievement Award for his discovery of natural killer (NK) cells. Don't miss his lecture on his pioneering discoveries, May 13, 18:00 at the CIMT Annual Meeting www.meeting.cimt.eu
March 25, 2025 at 9:17 AM
The Swedish cancer immunologist and researcher Rolf Kiessling @ki.se is the recipient of the 2025 CIMT Lifetime Achievement Award for his discovery of natural killer (NK) cells. Don't miss his lecture on his pioneering discoveries, May 13, 18:00 at the CIMT Annual Meeting www.meeting.cimt.eu
At #CIMT2025, Dario Neri @Philogen @ethzurich.bsky.social will take us on a journey through the past, present, and future of anti-cancer antibody-cytokine fusions—a field that holds immense promise for cancer therapy. Register now: ww.meeting.cimt.eu/registration
March 18, 2025 at 11:18 AM
At #CIMT2025, Dario Neri @Philogen @ethzurich.bsky.social will take us on a journey through the past, present, and future of anti-cancer antibody-cytokine fusions—a field that holds immense promise for cancer therapy. Register now: ww.meeting.cimt.eu/registration
Reposted by Association for Cancer Immunotherapy CIMT
Don't miss PICI Investigator Hideho Okada, MD, PhD (@ucsfhealth) present novel T-cell immunotherapy strategies for resistant gliomas at #CIMT2025. Can i-o crack glioblastoma's notorious defense systems? Find out May 12-14 at Europe's Cancer Immunotherapy Meeting. Register: www.meeting.cimt.eu
March 17, 2025 at 8:48 PM
Don't miss PICI Investigator Hideho Okada, MD, PhD (@ucsfhealth) present novel T-cell immunotherapy strategies for resistant gliomas at #CIMT2025. Can i-o crack glioblastoma's notorious defense systems? Find out May 12-14 at Europe's Cancer Immunotherapy Meeting. Register: www.meeting.cimt.eu
What makes the immune microenvironment in lung cancer a key determinant of patient survival?
Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
March 10, 2025 at 10:03 AM
What makes the immune microenvironment in lung cancer a key determinant of patient survival?
Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
The 22nd CIMT Annual Meeting will present Nikolaos Sgourakis from @upenn.bsky.social & Children's Hospital of Philadelphia: “Revealing, Decoding and Targeting the Endogenous Cancer Antigen Repertoire". Register to attend Europe's Cancer Immunotherapy Meeting at www.meeting.cimt.eu
March 4, 2025 at 1:27 PM
The 22nd CIMT Annual Meeting will present Nikolaos Sgourakis from @upenn.bsky.social & Children's Hospital of Philadelphia: “Revealing, Decoding and Targeting the Endogenous Cancer Antigen Repertoire". Register to attend Europe's Cancer Immunotherapy Meeting at www.meeting.cimt.eu
At #CIMT2025, Dr. Barbara Maier (CeMM Research Center for Molecular Medicine in Vienna) will present her latest research on tumor-draining lymph nodes as a target for cancer immunotherapy.
Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7
#cancerimmunotherapy
Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7
#cancerimmunotherapy
February 25, 2025 at 9:12 AM
At #CIMT2025, Dr. Barbara Maier (CeMM Research Center for Molecular Medicine in Vienna) will present her latest research on tumor-draining lymph nodes as a target for cancer immunotherapy.
Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7
#cancerimmunotherapy
Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7
#cancerimmunotherapy
Reposted by Association for Cancer Immunotherapy CIMT
Interested in investigating the principles that regulate the establishment of tumour environments that promote or inhibit the anti-tumour function of the immune system? Our group is currently recruiting a postdoctoral fellow.
Learn more about our research 👇
www.cruk.manchester.ac.uk/research-gro...
Learn more about our research 👇
www.cruk.manchester.ac.uk/research-gro...
MI/25/01 – Postdoctoral Scientist – Cancer Inflammation And Immunity Group | Cancer Research UK Manchester Institute
www.cruk.manchester.ac.uk
February 14, 2025 at 3:56 PM
Interested in investigating the principles that regulate the establishment of tumour environments that promote or inhibit the anti-tumour function of the immune system? Our group is currently recruiting a postdoctoral fellow.
Learn more about our research 👇
www.cruk.manchester.ac.uk/research-gro...
Learn more about our research 👇
www.cruk.manchester.ac.uk/research-gro...
Reposted by Association for Cancer Immunotherapy CIMT
Bioinformatician in Breast Cancer Immunology | Netherlands Cancer Institute
www.nki.nl
February 17, 2025 at 9:04 AM
Glioblastomas are notoriously resistant—can T-cell therapies change the game?
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
February 18, 2025 at 9:13 AM
Glioblastomas are notoriously resistant—can T-cell therapies change the game?
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
Did you know chances are high that you will be selected to give a short talk at the 22nd CIMT Annual Meeting? 10% of all abstract submissions are chosen for an oral presentation at Europe's Cancer Immunotherapy Meeting. Learn more at www.meeting.cimt.eu/call-for-abstracts #cancerimmunotherapy
February 13, 2025 at 12:10 PM
Did you know chances are high that you will be selected to give a short talk at the 22nd CIMT Annual Meeting? 10% of all abstract submissions are chosen for an oral presentation at Europe's Cancer Immunotherapy Meeting. Learn more at www.meeting.cimt.eu/call-for-abstracts #cancerimmunotherapy
Reposted by Association for Cancer Immunotherapy CIMT
🧪 Looking for a state-of-the-art education in #cancer #research?
✏️ The applications to the International Cancer Doctoral Programme (ICDP) at the @champalimaudf.bsky.social are open until 11 March 2025.
👉 More info: fchampalimaud.org/education-ar...
@itqbnova.bsky.social
✏️ The applications to the International Cancer Doctoral Programme (ICDP) at the @champalimaudf.bsky.social are open until 11 March 2025.
👉 More info: fchampalimaud.org/education-ar...
@itqbnova.bsky.social
Education Research | Champalimaud FoundationFundação Champalimaud Logotipo BotãoFundação ChampalimaudFundação Champalimaud Logotipo BotãoFundação Champalimaud Logotipo BotãoFundação Champalimaud Logot...
CR has developed and implemented several educational programmes, advanced courses and workshops, namely the PhD Programmes, INDP and ICDP.
fchampalimaud.org
February 11, 2025 at 2:49 PM
🧪 Looking for a state-of-the-art education in #cancer #research?
✏️ The applications to the International Cancer Doctoral Programme (ICDP) at the @champalimaudf.bsky.social are open until 11 March 2025.
👉 More info: fchampalimaud.org/education-ar...
@itqbnova.bsky.social
✏️ The applications to the International Cancer Doctoral Programme (ICDP) at the @champalimaudf.bsky.social are open until 11 March 2025.
👉 More info: fchampalimaud.org/education-ar...
@itqbnova.bsky.social
#WorldCancerDay 2025
Every cancer is unique. Every patient is unique. At CIMT, we bring together researchers dedicated to developing personalized #cancerimmunotherapies—harnessing the immune system to fight cancer in ways as individual as each patient’s disease. #UnitedByUnique. www.cimt.eu
Every cancer is unique. Every patient is unique. At CIMT, we bring together researchers dedicated to developing personalized #cancerimmunotherapies—harnessing the immune system to fight cancer in ways as individual as each patient’s disease. #UnitedByUnique. www.cimt.eu
February 4, 2025 at 3:50 PM
#WorldCancerDay 2025
Every cancer is unique. Every patient is unique. At CIMT, we bring together researchers dedicated to developing personalized #cancerimmunotherapies—harnessing the immune system to fight cancer in ways as individual as each patient’s disease. #UnitedByUnique. www.cimt.eu
Every cancer is unique. Every patient is unique. At CIMT, we bring together researchers dedicated to developing personalized #cancerimmunotherapies—harnessing the immune system to fight cancer in ways as individual as each patient’s disease. #UnitedByUnique. www.cimt.eu
At #CIMT2025, Dr. Matt Spitzer (@UCSF, @GladstoneInstitutes, @ParkerICI) explores how cancer & immunotherapy shape immune responses. His lab uses high-dimensional single-cell analysis to reveal systemic immune coordination in treatment. www.meeting.cimt.eu
#CancerImmunotherapy #PrecisionMedicine
#CancerImmunotherapy #PrecisionMedicine
February 4, 2025 at 9:46 AM
At #CIMT2025, Dr. Matt Spitzer (@UCSF, @GladstoneInstitutes, @ParkerICI) explores how cancer & immunotherapy shape immune responses. His lab uses high-dimensional single-cell analysis to reveal systemic immune coordination in treatment. www.meeting.cimt.eu
#CancerImmunotherapy #PrecisionMedicine
#CancerImmunotherapy #PrecisionMedicine
Learn how cancer and immune cells compete for nutrients in the tumor microenvironment. At #CIMT2025, Dr. Ilaria Elia (KU Leuven) will present on the metabolic cross-talk between cancer and immune cells in metastatic #melanoma. Register at www.meeting.cimt.eu
#CancerImmunotherapy #Immunometabolism
#CancerImmunotherapy #Immunometabolism
January 27, 2025 at 9:04 AM
Learn how cancer and immune cells compete for nutrients in the tumor microenvironment. At #CIMT2025, Dr. Ilaria Elia (KU Leuven) will present on the metabolic cross-talk between cancer and immune cells in metastatic #melanoma. Register at www.meeting.cimt.eu
#CancerImmunotherapy #Immunometabolism
#CancerImmunotherapy #Immunometabolism
At #CIMT2025 @dgfeller.bsky.social @ludwigcancer.bsky.social will share groundbreaking insights into predicting T-cell receptor (TCR) recognition in cancer by combining traditional T-cell assays with phage display technology and machine learning approaches. Register at www.meeting.cimt.eu
January 21, 2025 at 2:27 PM
At #CIMT2025 @dgfeller.bsky.social @ludwigcancer.bsky.social will share groundbreaking insights into predicting T-cell receptor (TCR) recognition in cancer by combining traditional T-cell assays with phage display technology and machine learning approaches. Register at www.meeting.cimt.eu
At #CIMT2025 Ronald Germain @niaidnews.bsky.social will present the cutting-edge world of optical imaging, where advanced 2D and 3D microscopy technology is unveiling how immune cells interact with cancer in unprecedented spatial and molecular detail. www.meeting.cimt.eu #cancerimmunotherapy
January 15, 2025 at 9:02 AM
At #CIMT2025 Ronald Germain @niaidnews.bsky.social will present the cutting-edge world of optical imaging, where advanced 2D and 3D microscopy technology is unveiling how immune cells interact with cancer in unprecedented spatial and molecular detail. www.meeting.cimt.eu #cancerimmunotherapy
Lei (Stanley) Qi, Stanford University, will present #CRISPR technology and synthetic biology at #CIMT2025 He invented the groundbreaking nuclease-dead dCas and developed precision #CRISPR tools like CRISPR interference, CRISPR activation (CRISPRa), and live cell DNA imaging. www.meeting.cimt.eu
January 13, 2025 at 11:49 AM
Lei (Stanley) Qi, Stanford University, will present #CRISPR technology and synthetic biology at #CIMT2025 He invented the groundbreaking nuclease-dead dCas and developed precision #CRISPR tools like CRISPR interference, CRISPR activation (CRISPRa), and live cell DNA imaging. www.meeting.cimt.eu
Registration and abstract submission for the 22nd CIMT Annual Meeting are now open! Submit your abstract and present your research at #Europe'sCancerImmunotherapyMeeting in Mainz, Germany, May 12-14, 2025. www.meeting.cimt.eu
January 6, 2025 at 1:39 PM
Registration and abstract submission for the 22nd CIMT Annual Meeting are now open! Submit your abstract and present your research at #Europe'sCancerImmunotherapyMeeting in Mainz, Germany, May 12-14, 2025. www.meeting.cimt.eu
Mark your calendars for the 22nd CIMT Annual Meeting in Mainz, Germany, May 12-14, 2025. Abstract submission and registration will open January 6. www.meeting.cimt.eu #cancerimmunotherapy
November 20, 2024 at 10:17 AM
Mark your calendars for the 22nd CIMT Annual Meeting in Mainz, Germany, May 12-14, 2025. Abstract submission and registration will open January 6. www.meeting.cimt.eu #cancerimmunotherapy